Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167582 · ClinicalTrials.gov registry record · Phase 3
Myocardial Ischemia and Transfusion Pilot
A Phase 3 study of Coronary Artery Disease and Myocardial Infarction, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 110
- Enrollment target
- 7
- Study locations
NCT01167582 is a Phase 3 study of Coronary Artery Disease and Myocardial Infarction that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 110 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (91% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT01167582, a Phase 3 study of Coronary Artery Disease and Myocardial Infarction, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 110 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to evaluate two approaches to red blood cell transfusion in anemic patients with acute coronary syndrome.
Conditions Studied
Interventions
- BIOLOGICAL Red blood cell transfusion
Study Locations (7)
New York
- Jack D. Weiler Hospital of Montefiore Medical Center - New York
- Montefiore Medical Center - The Bronx
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
- University of Pittsburgh Data Coordinating Center - Pittsburgh
Massachusetts
- Brigham and Women's Hospital - Boston
New Jersey
- Robert Wood Johnson University Hospital - New Brunswick
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01167582
The ClinicalTrials.gov registry entry for NCT01167582 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (91% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Red blood cell transfusion is the first listed.
NCT01167582 reports 7 study locations spanning 5 distinct geographic areas - top geographies include New York, Pennsylvania, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01167582 about?
NCT01167582 is a clinical study titled "Myocardial Ischemia and Transfusion Pilot". The purpose of this study is to evaluate two approaches to red blood cell transfusion in anemic patients with acute coronary syndrome.
What is the current status of trial NCT01167582?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 110 participants. The study started on 2009-09. Estimated completion is 2012-06.
What conditions does trial NCT01167582 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Myocardial Infarction, Unstable Angina.
What interventions are being tested in trial NCT01167582?
The interventions under investigation include: Red blood cell transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT01167582?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01167582 being conducted?
This trial has 7 study locations across Massachusetts, New Jersey, New York, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
RECRUITING · Phase 3
-
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
RECRUITING · Phase 3
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
RECRUITING · Phase 3
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
RECRUITING · Phase 3
-
PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients
ACTIVE NOT RECRUITING · Phase 3
-
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
ACTIVE NOT RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.